References
- Global Initiative for Asthma. Global strategy for asthma management and prevention; 2021. Available from: https://ginasthma.org/wp-content/uploads/2021/04/GINA-2021-Main-Report_FINAL_21_04_28-WMS.pdf. Accessed May 01, 2021.
- Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55:1901136. doi:10.1183/13993003.01136-2019
- Gibson PG. Inflammatory phenotypes in adult asthma: clinical applications. Clin Respir J. 2009;3:198–206. doi:10.1111/j.1752-699X.2009.00162.x
- Gao J, Wu F, Wu S, Yang X. Inflammatory subtypes in classic asthma and cough variant asthma. J Inflamm Res. 2020;13:1167–1173. doi:10.2147/JIR.S269795
- Malerba M, Ragnoli B, Azzolina D, Montuschi P, Radaeli A. Predictive markers of bronchial hyperreactivity in a large cohort of young adults with cough variant asthma. Front Pharmacol. 2021;12:630334. doi:10.3389/fphar.2021.630334
- Gao J, Wu H, Wu F. Small airway dysfunction in patients with cough variant asthma: a retrospective cohort study. BMC Pulm Med. 2021;21:49.
- Matsuoka H, Niimi A, Matsumoto H, et al. Inflammatory subtypes in cough-variant asthma: association with maintenance doses of inhaled corticosteroids. Chest. 2010;138:1418–1425. doi:10.1378/chest.10-0132
- Pavord ID. Blood eosinophil-directed management of airway disease. the past, present, and future. Am J Respir Crit Care Med. 2020;202:637–639. doi:10.1164/rccm.202004-1013ED
- Wardlaw AJ, Brightling C, Green R, Woltmann G, Pavord I. Eosinophils in asthma and other allergic diseases. Br Med Bull. 2000;56:985–1003. doi:10.1258/0007142001903490
- Martin RJ, Szefler SJ, King TS, et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol. 2007;119:73–80. doi:10.1016/j.jaci.2006.10.035
- Morice AH, Fontana GA, Belvisi MG, et al. ERS guidelines on the assessment of cough. Eur Respir J. 2007;29:1256–1276.
- Rybka-Fraczek A, Dabrowska M, Grabczak EM, et al. Blood eosinophils as a predictor of treatment response in adults with difficult-to-treat chronic cough. ERJ Open Res. 2021;7:00432–02021. doi:10.1183/23120541.00432-2021
- Dicpinigaitis PV. Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:75s–79s. doi:10.1378/chest.129.1_suppl.75S
- Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med. 2000;161:309–329.
- Paggiaro PL, Chanez P, Holz O, et al. Sputum induction. Eur Respir J Suppl. 2002;37:3s–8s. doi:10.1183/09031936.02.00000302
- Taylor SL, Leong LEX, Choo JM, et al. Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology. J Allergy Clin Immunol. 2018;141(94–103):e115. doi:10.1016/j.jaci.2017.03.044
- Johansson SG, Hourihane JO, Bousquet J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001;56:813–824. doi:10.1034/j.1398-9995.2001.t01-1-00001.x
- Global Initiative for Asthma. Global strategy for asthma management and prevention; 2016. Available from: https://ginasthma.org/wp-content/uploads/2019/01/2016-GINA.pdf. Accessed May 5, 2021.
- Rybka-Fraczek A, Dabrowska M, Grabczak EM, et al. Does bronchial hyperresponsiveness predict a diagnosis of cough variant asthma in adults with chronic cough: a cohort study. Respir Res. 2021;22:252. doi:10.1186/s12931-021-01845-2
- Tliba O, Panettieri RA Jr. Paucigranulocytic asthma: Uncoupling of airway obstruction from inflammation. J Allergy Clin Immunol. 2019;143:1287–1294. doi:10.1016/j.jaci.2018.06.008
- Thomson NC. Novel approaches to the management of noneosinophilic asthma. Ther Adv Respir Dis. 2016;10:211–234. doi:10.1177/1753465816632638